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Itch and worry about itch are predominant symptoms in atopic dermatitis (AD).
Mindfulness refers to paying attention in a certain way, non-judgementally and on
purpose. In patients with chronic pain, which shares several similarities with chronic itch,
a significant relationship between pain intensity, mindfulness and pain catastrophizing
has been found. The aim of this study was to investigate whether itch intensity and
mindfulness are related to itch catastrophizing in AD patients. Participants receiving
treatment for AD (n = 155; 58 male; mean age: 46.5 ± 12 years) completed measures
of itch-related catastrophizing (Itch Cognitions Questionnaire; ICQ) and mindfulness
(Comprehensive Inventory of Mindfulness; CHIME) during their stay at a rehabilitation
center in Borkum, Germany. In addition to other variables, their average itch intensity
during the last 2 weeks was assessed by means of a visual analog scale. A positive
relationship between itch intensity and itch catastrophizing was found (r = 0.409;
p < 0.01). Moreover, the mindfulness scales “acting with awareness,” “accepting and
non-judgemental orientation,” and “non-reactive orientation” were negatively related to
itch catastrophizing. A linear regression analysis revealed that itch intensity in combination
with “acting with awareness” was able to explain more than 27 % (corrected R2 = 0.274;
p < 0.001) of the variance of itch catastrophizing. Thus, itch intensity and certain facets
of mindfulness were associated with itch catastrophizing in AD patients. Psychological
interventions aiming to increase acting with awareness might have a buffering effect on
itch catastrophizing, which in turn could lead to lower itch intensity in patients with AD.
Future RCTs should test this hypothesis.
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INTRODUCTION
Itch or pruritus is an unpleasant bodily sensation usually
accompanied by scratching behavior (1). When itch lasts longer
than 6 weeks, it is regarded as chronic (2). Chronic itch is a
common symptom in patients with skin diseases like atopic
dermatitis (AD) (3). It has been shown that itch and scratching
behavior play a role in the maintenance and exacerbation of AD
as the mechanic stimulation of the skin through scratching can
provoke increased inflammation whilst also removing any topical
treatments that have been applied (4). Further inflammation then
subsequently triggers an additional itch sensation.
In addition to the direct behavior of scratching, psychological,
and social factors play an important role in the maintenance and
worsening of the itch-scratch cycle in AD. The biopsychosocial
model of chronic itch (5) proposes that internal (e.g., personality)
and external factors (e.g., stress) can lead to illness cognitions,
social reactions, and behaviors, which can increase physiological
responses (e.g., activation of certain brain areas) leading to itch
(5). Studies have reported that excessive worrying about the skin
condition is associated with the severity of physical symptoms
in AD and psoriasis (6). Schut et al. (7) found a significant
correlation between perceived stress, cognitive coping, and itch
intensity in patients with AD. In this study, the relationship
between stress and itch was mediated by itch-related cognitions
and patients, who reacted to stress with negative itch-related
cognitions reported higher itch intensities than patients with the
opposite cognitive reaction (7).
Mindfulness has been defined as “paying attention to the
present moment, non-judgmentally and on purpose” [(8), p4].
Sometimes, the term mindfulness is understood as synonym
of meditation. However, psychological models of “mindfulness”
posit that the construct is made up of a number of different facets
(9). Further, these facets are believed to be present to varying
degrees in all individuals and as such are thought to some extent
to represent “personality” variables. Thus, mindfulness comprises
more than just emotional awareness, but also e.g., awareness of
surrounding others, things, acting consciously (9). These facets
of mindfulness have been found to be significantly associated
with wellbeing (10). As postulated by Shenefelt (11) mindfulness
could help via psychoneuroimmunological pathways to reduce
itch. In a dermatology sample mindfulness explained a significant
proportion of the variance in social anxiety, anxiety, depression,
and health-related quality of life after controlling for subjective
severity of the skin condition (12). Moreover, there is some
evidence thatmindfulness based interventions can have a positive
effect on the skin status and wellbeing of patients with psoriasis
that can also be accompanied by itch [e.g., (13–15)].Whether also
participation in a short 2-week-mindfulness-based intervention
delivered at a German rehabilitation clinic is beneficial in patients
with the chronic, in many cases itchy skin disease psoriasis is
investigated at the moment (16).
Itch shares some similarity with pain (17) as both are
unpleasant sensations with common pathophysiological features
(18). In patients with chronic pain, mindfulness predicted pain
catastrophizing and moderated the relationship between pain
intensity and pain catastrophizing (19). Increasing levels of
mindfulness can be effective in reducing the experience of pain
(20), which may have important implications for people living
with AD given the significant association between itch and
chronic pain (21). Therefore, the current study aims to investigate
the relationship between itch intensity, mindfulness and itch
catastrophizing in patients with chronic itch. It is hypothesized
that in addition to itch intensity, levels of mindfulness will be
significant predictors of itch catastrophizing. In this context,
catastrophizing refers to a negative way of thinking about
the bodily symptom itch, e.g., the course or consequences of
it. Such negative thoughts measured in this study are “The
itching will never stop,” “I will scratch myself again until I look
horrible” (22).
MATERIALS AND METHODS
Inclusion and Exclusion Criteria and
Procedure
Participants were receiving treatment at the rehabilitation clinic
on Borkum, Germany and were assessed for eligibility and
recruited to the study by KL (medical student) and CZ
(Consultant and Lead Dermatologist). Inclusion criteria included
being between the ages of 18–70 and having a verified diagnosis
of atopic dermatitis of at least 1 year duration. In order to
ensure that participants could complete the survey, proficiency
in the German language was also required. Exclusion criteria
included having a comorbid severe psychological or psychiatric
condition or another skin disease associated with itch, or
having another long-term disease which was in the focus at
the time of investigation. Participants were asked to complete
the questionnaires and return them during their 1st week at
the clinic.
Ethics
Ethical approval was gained at the University of Gießen
(AZ: 210/15). Information on the study was provided to all




The Comprehensive inventory of mindfulness experiences
(CHIME) (9) was used tomeasure different facets of mindfulness.
It provides a multi-dimensional assessment of mindfulness
and consists of 37 items measured on a six-point scale (1-6).
Participants were asked to rate levels of mindfulness over the
last 2 weeks. Eight subscales of mindfulness were measured;
(1) awareness toward internal experiences, (2) awareness
toward external experiences, (3) acting with awareness, (4)
accepting and non-judgemental orientation, (5) non-reactivity,
(6) openness to experiences, (7) relativity of thoughts, and (8)
insightful understanding.
Itch Catastrophizing
The Itch Cognitions Questionnaire (22, 23) was used to measure
itch catastrophizing. Participants were asked to rate the frequency
of thoughts they had regarding itch over the past 2 weeks, for
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TABLE 1 | Description of the sample (n = 155 patients with atopic dermatitis).
Gender Female Male Missing data
97 (62.6%) 58 (37.4%) /
Age (x ± SD) 46.8 ± 11.5 46 ± 13.0 /
Education No formal qualification: n = 1 No formal qualification: n = 2 /
Secondary school qualification: n = 70 Secondary school qualification: n = 41
College or university degree: n = 26 College or university degree: n = 15
Self-reported physical comorbidities Yes: n = 48 Yes: n = 38 /
CHIME 1 (x ± SD) 4.49 ± 0.89 4.39 ± 0.86 /
CHIME 2 (x ± SD) 4.84 ± 0.96 4.67 ± 0.81 /
CHIME 3 (x ± SD) 3.97 ± 1.00 3.95 ± 0.89 /
CHIME 4 (x ± SD) 3.25 ± 1.07 3.34 ± 0.99 /
CHIME 5 (x ± SD) 3.48 ± 0.98 3.47 ± 0.89 1
CHIME 6 (x ± SD) 3.75 ± 1.00 3.74 ± 0.68 1
CHIME 7 (x ± SD) 3.84 ± 1.01 3.73 ± 0.72 1
CHIME 8 (x ± SD) 3.91 ± 0.89 3.75 ± 0.81 /
Itch Inten (x ± SD) 5.32 ± 2.68 5.89 ± 2.27 2
Itch Cat (x ± SD) 2.34 ± 0.87 2.33 ± 0.95 5
PO-SCORAD (× ± SD) 46.69 ± 20.55 49.74 ± 18.96 20
Itch Cat, Itch Catastrophizing; Itch Inten, Itch Intensity; values for the CHIME-scales can range from 1 to 6 and values for Itch Cat can range from 0 to 4. x, mean; SD, standard deviation.
CHIME 1: awareness toward internal experiences.
CHIME 2: awareness toward external experiences.
CHIME 3: acting with awareness.
CHIME 4: accepting and non-judgemental orientation.
CHIME 5: non-reactivity.
CHIME 6: openness to experiences.
CHIME 7: relativity of thoughts.
CHIME 8: insightful understanding.
example “The itching will get worse and worse.” The questionnaire
consists of 20 statements measured on a five-point Likert scale
ranging from 0 (thought never occurs) to 4 (the thought
usually occurs) which can be combined to the two scales “itch
catastrophizing” and “itch coping.” In the current study we were
only interested in the scale “itch catastrophizing.”
Itch Intensity
Itch intensity during the last 2 weeks was measured by a visual
analog scale ranging from 0 to 10. The item to measure itch
was “Please evaluate on this scale how intense your itch was on
average during the last 2 weeks.”
Atopic Dermatitis Severity—Self Report
The Patient Orientated SCORing Dermatitis Index (PO-
SCORAD) (24) was used tomeasure the self-rated severity of AD.
Participants indicate the area of the body affected (POSCORAD-
A), the severity of the condition including redness, scratch
lesions, skin dryness, edema, and skin thickening (POSCORAD-
B). In addition, using visual analog scales participants indicated
the severity of itching and insomnia (POSCORAD-C). As for
the SCORAD, also POSCORAD scores can range from 0 to
103 with higher scores indicating a more severe AD. SCORAD-
scores below 25 indicate a mild AD, scores between 25 and 50
indicate a moderate AD and scores > 50 indicate a severe AD
(25). In former studies, it was shown that SCORAD scores rated
by clinicians and PO-SCORAD scores rated by patients highly
correlate (24, 26).
Other Variables
Besides the before mentioned variables, further data on
alexithymia, self-rated causes of itch, sociodemographic variables
and comorbidities were gathered which are included in the
doctoral thesis of the first author of this article.
Statistical Analysis
Statistical analyses were conducted using SPSS 24. Due to
the fact that variables were not normally distributed in all
cases, Spearman-Rank-correlations were conducted in addition
to Pearson correlations to investigate the associations between
mindfulness, itch catastrophizing, and itch intensity. These
analyses did not reveal substantially different results (differences
in r’s < 0.045). After testing whether the assumptions for a linear
regression analysis (27) were fulfilled this method was used to
investigate how much variance in itch catastrophizing could be
predicted by itch intensity and the mindfulness subscales related
to itch catastrophizing in the correlation analyses (“method of
best predictors”). In the regression model, the control variables
age and sex were entered in the first step of the analysis, itch
intensity during the last 2 weeks was entered in the second step
and the mindfulness subscales were entered in step three of
the analysis.
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TABLE 2 | Results of the correlation analyses.
0: Itch Cat 1 2 3 4 5 6 7 8 9 10
1 Itch Inten 0.409** 1
2 CHIME 1 0.039 −0.071 1
3 CHIME 2 −0.088 −0.044 0.635*** 1
4 CHIME 3 −0.373*** −0.130 0.190* 0.250** 1
5 CHIME 4 −0.198* −0.129 0.243** 0.333*** 0.352*** 1
6 CHIME 5 −0.260** −0.053 0.383*** 0.503*** 0.375*** 0.577*** 1
7 CHIME 6 0.084 −0.085 −0.003 0.054 −0.264*** −0.214** −0.029 1
8 CHIME 7 0.006 −0.087 0.425*** 0.359*** 0.000 0.138 −258** 0.189* 1
9 CHIME 8 −0.028 −0.074 0.401*** 0.445*** 0.014 0.261*** 0.441*** 0.163* 0.608*** 1
10 Age −0.157 −0.166* −0.034 0.119 0.189* 0.041 0.154 −0.109 −0.063 −0.006 1
11 Sex 0.004 −0.109 0.059 0.089 0.012 −0.040 0.005 0.006 0.062 0.089 0.031
Shown are correlations between itch catastrophizing, average itch intensity during the last 2 weeks, the eight mindfulness scales measured by CHIME and sex and age. Bold numbers
indicate significant correlations.
***Indicate that the correlation is significant on the 0.001 niveau,
**indicate that the correlation is significant on the 0.01 niveau, *indicates that the correlation is significant on the 0.05 niveau.
The number of patients included in the analyses varies between n = 149 and 155.
Itch Cat, Itch Catastrophizing; Itch Inten, Itch Intensity.
CHIME 1: awareness toward internal experiences.
CHIME 2: awareness toward external experiences.
CHIME 3: acting with awareness.
CHIME 4: accepting and non-judgmental orientation.
CHIME 5: non-reactivity.
CHIME 6: openness to experiences.
CHIME 7: relativity of thoughts.
CHIME 8: insightful understanding.
RESULTS
Sample Characteristics
One hundred and sixty three AD patients took part in the
study, 8 had to be excluded from the analyses, because they
did not fulfill the inclusion criteria. Thus, the final sample
size consisted of 155 AD patients (58 men and 97 women).
Their mean age (data available from all n = 155) was 46.5
± 12 years. Their mean AD severity (data available from
n = 135 patients) measured by the PO-SCORAD was 47.9
± 19.9, which indicates that on average patients suffered
from a moderate AD. Twenty-one patients had mild AD,
72 moderate and 42 severe AD. Patients who reported to
have a physical comorbidity did not differ from patients
without self-reported physical comorbidity regarding itch-
catastrophizing (p = 0.763) or itch-intensity (p= 0.337). For
more information regarding the sample characteristics, please
see Table 1.
Results of the Correlation Analyses
The Pearson correlation analyses revealed that itch
catastrophizing and itch intensity during the last 2 weeks
were significantly positively related (r = 0.409). Moreover,
itch catastrophizing was significantly negatively related
to the mindfulness subscales acting with awareness (r =
−0.373), accepting and non-judgemental orientation (r
= −0.198) and non-reactivity (r = −0.260). For the full
correlation matrix, please see Table 2. Spearman-Rank-
correlations also revealed significant correlations between
itch-catastrophizing and the mindfulness subscales “acting with
awareness,” “accepting and non-judgemental orientation,” and
‘‘non-reactivity” (p < 0.05).
Results of the Regression Analyses
The regression analysis showed that 27.4 % of the variance of
itch catastrophizing could be predicted by itch intensity and the
mindfulness-scale “acting with awareness” (R²= 0.284; corrected
R²= 0.274; F = 28.728; p< 0.001). Hereby, 17.1% of the variance
were explained by itch-intensity and 10.3% by the mindfulness-
scale “acting with awareness” (also see Figure 1).
DISCUSSION
The current study is the first to examine the relationship between
mindfulness and itch and mindfulness and itch-catastrophizing
in patients with AD. There was no significant relationship
between itch intensity and mindfulness; however, there was a
significant negative relationship between the mindfulness scale
“acting with awareness” and itch catastrophizing.
This finding is in line with the results of previous studies
in which mindfulness and especially the mindfulness
facets “acting with awareness” and non-reactivity were
related to pain catastrophizing and other types of
psychological distress (12, 19). This is an important finding
as catastrophic thoughts and physiological reactivity are
important maintaining factors to itch (6). Furthermore,
studies using itch induction suggest that a focus on bodily
sensations and catastrophizing of upcoming itch stimuli
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FIGURE 1 | Results of the regression analysis. 27.4% of itch catastrophizing could be explained by itch intensity during the last 2 weeks and the mindfulness scale
“acting with awareness”.
lead to greater itch intensity or more profound scratching
behavior (28, 29).
Our findings suggest that acting with awareness, essentially
being more aware of bodily sensations and not reacting to
them automatically, may reduce the likelihood of automatic
scratching in response to itch. This in turn could then lead
to less negative thinking about the skin as skin lesions would
not occur that often anymore. In this context, it has already
been shown that higher levels of present moment awareness
can reduce negative thinking, a characteristic of depression and
anxiety (30).
Intervention studies have shown promising results for
mindfulness interventions in patients living with long term
health conditions and chronic pain (31, 32). In dermatology,
mindfulness interventions have been used in patients living
with psoriasis with promising results (13, 14, 33). Audio-guided
meditations used as an adjunct to light treatment increased the
rates of skin clearing (13), and a structured 8-week mindfulness
intervention, Mindfulness-based cognitive group therapy, was
found to improve dermatology quality of life and self-reported
psoriasis severity (14). In atopic dermatitis first results of positive
effects in a small patient therapy group were demonstrated (34).
However, D’Alton et al. (33) conducted a randomized controlled
trial of mindfulness-based interventions in psoriasis and found
that whilst participants reported perceiving the interventions as
beneficial, there was no significant difference found on distress,
symptom burden, or quality of life at completion, or at 6 or
12-month follow-up. Clearly, whilst mindfulness interventions
show promise, and our study further supports the theoretical
rationale for using it as an intervention where itch is a factor,
further examination of mindfulness interventions in a range of
skin conditions is required.
Limitations
There are limitations to the current study. First, this study is
a cross-sectional study and therefore conclusions on causation
cannot be drawn. Randomized, controlled trials in which
“acting with awareness” as one important facet of mindfulness
is manipulated by participation in a mindfulness based
intervention could provide answers on causal relationships
between mindfulness and itch/itch catastrophizing. Further,
as participants were recruited at a rehabilitation clinic and
were experiencing moderate or severe AD in most cases, the
generalisability of our findings to community samples needs
to be acknowledged, and be investigated in future studies. In
addition, given that AD is known to be associated with anxiety
and depression future studies might investigate the role that both
“acting with awareness” and catastrophizing play in significant
psychological distress associated with AD.
CONCLUSION
The current study findings indicate that higher levels of a specific
facet ofmindfulness termed “acting with awareness” are related to
lower levels of itch catastrophizing. This finding is important as it
suggests that psychological interventions should seek to increase
acting with awareness in patients with AD as a way of improving
patient outcomes associated with problematic itch.
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